Companies › CODX
Co-Diagnostics Inc (CODX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001692415 · EDGAR filings · Updated 2026-07-27
Co-Diagnostics Inc (CODX) has reported institutional ownership of 1.4%, with 14 institutional managers holding positions valued at $91.5K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
- 2026-07-27 — Current report (8-K) filed
- 2026-07-27 — Prospectus supplement (424B5) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-21 — Proxy statement (DEF 14A) filed
- 2026-07-10 — PRE 14A filed
- 2026-06-03 — SCHEDULE 13G filed
- 2026-05-29 — EFFECT filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Co-Diagnostics Inc has 14 institutional holders and institutional ownership of 1.4%.
Insider activity
Insiders reported 20 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
AIM IMMUNOTECH INC (AIM) · Jaguar Health Inc (JAGX) · Lifeward Inc (LFWD) · PLURI INC (PLUR) · CYTODYN INC (CYDY) · iSpecimen Inc (ISPC)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.